![Acticor Biotech](/common/images/company/EU_ALACT.png)
Regulatory News: ACTICOR BIOTECH (ISIN : FR0014005OJ5 – ALACT), société biopharmaceutique au stade clinique qui développe le glenzocimab, un médicament innovant pour le traitement des urgences...
Article 223-16 du Règlement Général de l'Autorité des Marchés Financiers Regulatory News: ACTICOR BIOTECH (ISIN : FR0014005OJ5 – ALACT), société biopharmaceutique au stade clinique qui développe...
Annual General Meeting to be held on September 13, 2024, to approve the financial statements for the year ending December 31, 2023 Update on the glenzocimab clinical development plan published...
Article 223-16 du Règlement Général de l'Autorité des Marchés Financiers Regulatory News: ACTICOR BIOTECH (ISIN : FR0014005OJ5 – ALACT), société biopharmaceutique au stade clinique qui développe...
New analyses of ACTISAVE phase 2/3 study show positive trends for glenzocimab in subpopulations of patients Continuation of clinical studies: Phase 2/3 GREEN in Ischemic stroke and Phase 2b...
Acticor Biotech updates its glenzocimab clinical development plan for the treatment of cardiovascular emergencies New analyses of ACTISAVE phase 2/3 study show positive trends for...
Regulatory News: ACTICOR BIOTECH (FR0014005OJ5 - ALACT), a clinical stage biopharmaceutical company developing glenzocimab, an innovative drug for the treatment of cardiovascular emergencies...
Des données sur des sous-groupes spécifiques ouvrent la voie à de nouvelles perspectives Poursuite réaffirmée de la conduite des études de phase 2/3 GREEN et de phase 2b LIBERATE Regulatory...
University of Birmingham and Acticor Biotech News ReleaseLimited clinical access available The University of Birmingham and Acticor Biotech announce the First Patient treated in LIBERATE, first...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.032 | -5.59440559441 | 0.572 | 0.582 | 0.522 | 1985 | 0.5555338 | DE |
4 | -0.178 | -24.791086351 | 0.718 | 0.72 | 0.421 | 12150 | 0.5400178 | DE |
12 | 0.12 | 28.5714285714 | 0.42 | 1.24 | 0.359 | 77299 | 0.85094588 | DE |
26 | -4.36 | -88.9795918367 | 4.9 | 5.3 | 0.27 | 70909 | 1.07292818 | DE |
52 | -5.02 | -90.2877697842 | 5.56 | 6 | 0.27 | 38061 | 1.27711774 | DE |
156 | -6.56 | -92.3943661972 | 7.1 | 11 | 0.27 | 15960 | 2.01500889 | DE |
260 | 0.36 | 200 | 0.18 | 11 | 0.11 | 66952 | 1.19598269 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.